Dr.Paney's hard work aside, he's no longer involved with Nicosan.
Nicosan has never been proven to work, and since it's role is that of a drug, therefore it isn't.
There is a way for previous investors to perhaps regain all of their losses, and perhaps even make some additional money. That will not be accomplished by dragging millions of debt forward, and waiting for crumbs to trickle down to retail investors. Monty's 'plan' is Monty's plan, and none of the creditors will be on board with it.
As for your personal 25 years of investing experience, I have no idea. If your investment in XKEM serves as an analogue to this end, then your investors have their windfall.
Well, with all the hard work DP has done over the years, the company now has a proven drug ( I know you may disagree
Market Data 
Markets 
AI
